^(131)I治疗甲状腺疾病对甲状旁腺功能的影响  

Effect of ^(131)I therapy on parathyroid function in thyroid diseases

作　　者：陈紫巍 木尼热·阿不都外力 吴竹娟 苏安平[1] Ziwei Chen;Abuduwaili Munire;Zhujuan Wu;Anping Su(Department of Thyroid Surgery,West China Hospital,Sichuan University,Chengdu 610041,China)

机构地区：[1]四川大学华西医院甲状腺外科,成都610041

出　　处：《国际放射医学核医学杂志》2023年第7期430-434,共5页International Journal of Radiation Medicine and Nuclear Medicine

基　　金：四川省卫生健康委员会科研项目(20PJO57);四川省科技厅资助项目(2021YFS0103);中国健康促进基金会项目(HX22-228HX-H2204083)。

摘　　要：^(131)I常用于甲状腺疾病的治疗,但其是否会引起与甲状腺毗邻的甲状旁腺的功能改变尚存争议.目前,部分研究结果显示^(131)I治疗会增加甲状旁腺腺瘤的发生、引起甲状旁腺功能改变,但也有研究结果显示^(131)I治疗对甲状旁腺功能无明显影响.笔者对既往^(131)I治疗与甲状旁腺疾病相关性的研究进行综述,对相关研究的不足之处进行分析,为进一步开展更加深入的研究奠定基础.^(131)I is commonly used in the treatment of thyroid diseases,but there is no unified conclusion whether radiation will cause changes in the function of adjacent parathyroid gland.Some studies have shown that ^(131)I therapy will increase the risk of parathyroid adenoma and cause changes in parathyroid gland function,but other studies have shown that ^(131)I therapy will not affect parathyroid gland function.This article reviews the previous studies on the correlation between ^(131)I therapy and parathyroid diseases,and analyzes the shortcomings of the relevant literatures to provide a basis for further research.

关 键 词：碘放射性同位素 甲状腺疾病 甲状旁腺 放射疗法 

分 类 号：R736.1[医药卫生—肿瘤]